DDI-DrugBank.d634.s0 >> Anticoagulants (oral): The activity of oral anticoagulants may be potentiated by anti-vitamin-K activity attributed to methimazole. >> 0-13,44-57,119-129
DDI-DrugBank.d634.s1 >> -adrenergic blocking agents: Hyperthyroidism may cause an increased clearance of beta ratio. >> 1-26
DDI-DrugBank.d634.s2 >> A dose reduction of beta-adrenergic blockers may be needed when a hyperthyroid patient becomes euthyroid. >> 20-43
DDI-DrugBank.d634.s3 >> Digitalis glycosides: Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; >> 0-19,101-119
DDI-DrugBank.d634.s4 >> reduced dosage of digitalis glycosides may be required. >> 18-37
DDI-DrugBank.d634.s5 >> Theophylline: Theophylline clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid; >> 0-11,14-25,89-100
DDI-DrugBank.d634.s6 >> a reduced dose of theophylline may be needed. >> 18-29
